Tel Aviv University Researchers Develop New Technology to Deliver Antibodies Into Brain Cells
Tel Aviv University researchers Prof. Ben Maoz and Prof. Uri Ashery, together with colleagues at Cornell University and the Technion, have developed a new technology that enables therapeutic antibodies to enter cells—including brain cells. In a preclinical model of Parkinson’s disease, the approach significantly reduced harmful aggregates of alpha-synuclein, a protein closely associated with the… Read More